EndoTAG-1
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for EndoTAG-1, covering 2008-11-14 to 2023-04-26. Get the full timeline:
Most recent: Clinical Trial Update: A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer [Phase 3]